Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model

Transplantation
K G LurieB A Reitz

Abstract

Accelerated graft arteriosclerosis is a major cause of death in human heart transplantation. Despite many investigations, the pathogenesis of this disease remains undetermined and its control inadequate. In this study using a rat heart transplant model and cyclosporin A, a new immunosuppressant, acute rejection was prevented but arteriosclerotic-like vessel disease still developed consistently as early as 20 days postoperatively. The combination of cyclosporin A and dipyridamole prevented the development of this vessel disease in transplanted hearts at 20 and 50 days postoperatively. Sulfinpyrazone and cyclosporin A reduced but did not prevent the disease. These findings suggest that immunologically induced graft arteriosclerosis can be prevented in transplanted rat hearts by the combination of cyclosporin A and dipyridamole.

Citations

Dec 1, 1990·Biulleten' eksperimental'noĭ biologii i meditsiny·V Iu KhalatovO S Medvedev
Oct 1, 1984·Agents and Actions·A W ThomsonJ G Simpson
Oct 1, 1989·International Journal of Cardiology·H Davies, S al-Tikriti
Aug 1, 1988·Journal of the American College of Cardiology·S Z GaoS A Hunt
Jun 1, 1990·Journal of the American College of Cardiology·J H IpJ H Chesebro
Jun 29, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Louis P PerraultMichel Carrier
Jun 1, 1985·American Journal of Surgery·B G SommerR M Ferguson
Nov 14, 1997·The Annals of Thoracic Surgery·J S AllanJ C Madsen
Nov 15, 2002·Transplantation Proceedings·Y KobayashiH Matsuda
Jun 24, 1998·Transplantation Proceedings·V LangeR E Silber
Jul 1, 1985·Journal of the American College of Cardiology·R S NitkinJ S Schroeder
Aug 15, 1998·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·K HamanoK Esato
Jun 27, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·S Kitagawa-SakakidaR Shirakura
Apr 3, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Markus RichterHans Georg Olbrich
Jan 22, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Stuart L HouserJoren C Madsen
May 18, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·M HachidaH Koyanagi
Mar 9, 2002·Transplantation·James S AllanDavid H Sachs
Mar 28, 2003·Transplantation·Joshua D MezrichDavid H Sachs
Jan 1, 1995·Transplant International : Official Journal of the European Society for Organ Transplantation·M D'SilvaP McMaster
Aug 1, 1993·Immunological Reviews·P HäyryE Taskinen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.